{
    "xml": "<topic id=\"PHP33109\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/mirabegron\" basename=\"mirabegron\" title=\"MIRABEGRON\">\n<title>MIRABEGRON</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1245\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\">Mirabegron</xref>\n</p>\n<data name=\"vtmid\">703804000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_306824104\" title=\"Beta3-adrenoceptor agonists\">Beta3-adrenoceptor agonists</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP69588\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/mirabegron\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Urinary frequency, urgency, and urge incontinence</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70090\" outputclass=\"contraindications\" rev=\"1.6\" parent=\"/drugs/mirabegron\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Severe hypertension</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70300\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/mirabegron\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">History of QT-interval prolongation</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69481\" outputclass=\"interactions\" rev=\"1.29\" parent=\"/drugs/mirabegron\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (mirabegron).</p>\n<p>Caution with concomitant use with drugs that prolong the QT interval.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Hepatic impairment</p>\n<p>\n<i>With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin </i>reduce dose to 25&#8239;mg once daily in mild impairment, and avoid in moderate impairment.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Renal impairment</p>\n<p>\n<i>With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin </i>reduce dose to 25&#8239;mg once daily if eGFR less than 30&#8211;89&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, and avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73853\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/mirabegron\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Tachycardia</ph>; <ph outputclass=\"sideEffect\">urinary-tract infection</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Atrial fibrillation</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">gastritis</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">joint swelling</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">vulvovaginal infection</ph>; <ph outputclass=\"sideEffect\">vulvovaginal pruritus</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70199\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/mirabegron\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Contraception advised in women of child-bearing potential.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69324\" outputclass=\"pregnancy\" parent=\"/drugs/mirabegron\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;toxicity in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70414\" outputclass=\"breastFeeding\" parent=\"/drugs/mirabegron\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69713\" outputclass=\"hepaticImpairment\" parent=\"/drugs/mirabegron\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose to 25&#8239;mg once daily in moderate impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73982\" outputclass=\"renalImpairment\" parent=\"/drugs/mirabegron\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose to 25&#8239;mg once daily if eGFR 15&#8211;29&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR less than 15&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73541\" outputclass=\"nationalFunding\" rev=\"1.17\" parent=\"/drugs/mirabegron\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA290</p>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\r\n<p outputclass=\"title\">Mirabegron for treating symptoms of overactive bladder (June 2013)</p>\r\n<p>Mirabegron is recommended as an option only for patients in whom antimuscarinic drugs are ineffective, contra-indicated, or not tolerated; patients currently receiving mirabegron who do not meet these criteria should have the option to continue until they and their clinician consider it appropriate to stop.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA290\">www.nice.org.uk/TA290</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP33109-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/mirabegron\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77094\" title=\"Modified-release tablet\" namespace=\"/drugs/mirabegron/modified-release-tablet\">Modified-release tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e127136\" href=\"#bnf_d1e127136\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e127136</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e127173\" href=\"#bnf_d1e127173\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e127173</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e127195\" href=\"#bnf_d1e127195\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e127195</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e127229\" href=\"#bnf_d1e127229\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e127229</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e53960\" href=\"#bnf_d1e53960\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e53960</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1365\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"Ketoconazole\" count=\"1\" rel=\"backlink\">Ketoconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e18283\" href=\"#bnf_d1e18283\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e18283</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_168\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"Clarithromycin\" count=\"1\" rel=\"backlink\">Clarithromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e58367\" href=\"#bnf_d1e58367\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e58367</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_302\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"Itraconazole\" count=\"1\" rel=\"backlink\">Itraconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e80459\" href=\"#bnf_d1e80459\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e80459</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_400\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"Ritonavir\" count=\"1\" rel=\"backlink\">Ritonavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78573\" namespace=\"/treatment-summaries/urinary-frequency-enuresis-and-incontinence\" title=\"Urinary frequency, enuresis and incontinence\" count=\"1\" rel=\"backlink\">Urinary frequency, enuresis and incontinence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1245\" namespace=\"/interactions/list-of-drug-interactions/mirabegron\" title=\"Mirabegron\" count=\"1\" rel=\"link\">Mirabegron</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77094\" namespace=\"/drugs/mirabegron/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n</links>\n</topic>",
    "id": "PHP33109",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/mirabegron",
    "basename": "mirabegron",
    "title": "MIRABEGRON",
    "interactants": [
        {
            "id": "bnf_int_1245",
            "label": "Mirabegron"
        }
    ],
    "vtmid": "703804000",
    "drugClassification": [
        "Beta3-adrenoceptor agonists"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Urinary frequency, urgency, and urge incontinence",
                        "html": "Urinary frequency, urgency, and urge incontinence"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50 mg once daily.",
                        "html": "<p>50&#8239;mg once daily.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Severe hypertension",
                "html": "Severe hypertension"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "History of QT-interval prolongation",
                "html": "History of QT-interval prolongation"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (mirabegron).\n\nCaution with concomitant use with drugs that prolong the QT interval.",
                "html": "<p>Appendix 1 (mirabegron).</p><p>Caution with concomitant use with drugs that prolong the QT interval.</p>"
            },
            {
                "type": "general",
                "title": "Hepatic impairment",
                "textContent": "With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin reduce dose to 25 mg once daily in mild impairment, and avoid in moderate impairment.",
                "html": "<p>\n<i>With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin </i>reduce dose to 25&#8239;mg once daily in mild impairment, and avoid in moderate impairment.</p>"
            },
            {
                "type": "general",
                "title": "Renal impairment",
                "textContent": "With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin reduce dose to 25 mg once daily if eGFR less than 30&#8211;89 mL/minute/1.73 m2, and avoid if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>\n<i>With concomitant use of strong cytochrome P450 inhibitors such as itraconazole, ketoconazole, ritonavir, or clarithromycin </i>reduce dose to 25&#8239;mg once daily if eGFR less than 30&#8211;89&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, and avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Tachycardia",
                        "html": "Tachycardia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "urinary-tract infection",
                        "html": "urinary-tract infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Atrial fibrillation",
                        "html": "Atrial fibrillation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gastritis",
                        "html": "gastritis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "joint swelling",
                        "html": "joint swelling",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vulvovaginal infection",
                        "html": "vulvovaginal infection",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "vulvovaginal pruritus",
                        "html": "vulvovaginal pruritus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Contraception advised in women of child-bearing potential.",
                "html": "<p>Contraception advised in women of child-bearing potential.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;toxicity in animal studies.",
                "html": "<p>Avoid&#8212;toxicity in <i>animal</i> studies.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;present in milk in animal studies.",
                "html": "<p>Avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose to 25 mg once daily in moderate impairment.",
                "html": "<p>Reduce dose to 25&#8239;mg once daily in moderate impairment.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe impairment&#8212;no information available.",
                "html": "<p>Avoid in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose to 25 mg once daily if eGFR 15&#8211;29 mL/minute/ 1.73 m2.",
                "html": "<p>Reduce dose to 25&#8239;mg once daily if eGFR 15&#8211;29&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR less than 15 mL/ minute/1.73 m2&#8212;no information available.",
                "html": "<p>Avoid if eGFR less than 15&#8239;mL/ minute/1.73&#8239;m<sup>2</sup>&#8212;no information available.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA290",
                        "label": "www.nice.org.uk/TA290"
                    }
                ],
                "fundingIdentifier": "NICE TA290",
                "textContent": "With oral use Mirabegron for treating symptoms of overactive bladder (June 2013) Mirabegron is recommended as an option only for patients in whom antimuscarinic drugs are ineffective, contra-indicated, or not tolerated; patients currently receiving mirabegron who do not meet these criteria should have the option to continue until they and their clinician consider it appropriate to stop.\n\nwww.nice.org.uk/TA290",
                "html": "<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p> <p outputclass=\"title\">Mirabegron for treating symptoms of overactive bladder (June 2013)</p> <p>Mirabegron is recommended as an option only for patients in whom antimuscarinic drugs are ineffective, contra-indicated, or not tolerated; patients currently receiving mirabegron who do not meet these criteria should have the option to continue until they and their clinician consider it appropriate to stop.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA290\">www.nice.org.uk/TA290</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77094",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e127136": [
            {
                "id": "bnf_d1e127136",
                "label": "bnf_d1e127136",
                "type": "#bnf_d1e127136"
            }
        ],
        "#bnf_d1e127173": [
            {
                "id": "bnf_d1e127173",
                "label": "bnf_d1e127173",
                "type": "#bnf_d1e127173"
            }
        ],
        "#bnf_d1e127195": [
            {
                "id": "bnf_d1e127195",
                "label": "bnf_d1e127195",
                "type": "#bnf_d1e127195"
            }
        ],
        "#bnf_d1e127229": [
            {
                "id": "bnf_d1e127229",
                "label": "bnf_d1e127229",
                "type": "#bnf_d1e127229"
            }
        ],
        "#bnf_d1e53960": [
            {
                "id": "bnf_d1e53960",
                "label": "bnf_d1e53960",
                "type": "#bnf_d1e53960"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_1365",
                "label": "Ketoconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_168",
                "label": "Clarithromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_302",
                "label": "Itraconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_400",
                "label": "Ritonavir",
                "type": "interaction"
            }
        ],
        "#bnf_d1e18283": [
            {
                "id": "bnf_d1e18283",
                "label": "bnf_d1e18283",
                "type": "#bnf_d1e18283"
            }
        ],
        "#bnf_d1e58367": [
            {
                "id": "bnf_d1e58367",
                "label": "bnf_d1e58367",
                "type": "#bnf_d1e58367"
            }
        ],
        "#bnf_d1e80459": [
            {
                "id": "bnf_d1e80459",
                "label": "bnf_d1e80459",
                "type": "#bnf_d1e80459"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78573",
                "label": "Urinary frequency, enuresis and incontinence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1245",
                "label": "Mirabegron",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77094",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            }
        ]
    }
}